HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrey Korshunov Selected Research

Vardenafil Dihydrochloride (Levitra)

1/2021ABCB1 inhibition provides a novel therapeutic target to block TWIST1-induced migration in medulloblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrey Korshunov Research Topics

Disease

116Neoplasms (Cancer)
01/2024 - 01/2002
63Medulloblastoma
12/2023 - 05/2004
20Glioma (Gliomas)
01/2023 - 05/2008
20Ependymoma
10/2021 - 07/2002
18Astrocytoma (Pilocytic Astrocytoma)
06/2023 - 07/2002
16Brain Neoplasms (Brain Tumor)
01/2023 - 12/2008
15Glioblastoma (Glioblastoma Multiforme)
01/2021 - 07/2002
11Primitive Neuroectodermal Tumors (PNET)
11/2021 - 09/2007
8Carcinogenesis
01/2020 - 11/2003
7Neoplasm Metastasis (Metastasis)
01/2021 - 03/2009
5Oligodendroglioma
12/2022 - 01/2002
5Disease Progression
01/2021 - 03/2009
3Neuroepithelial Neoplasms (Gliomatosis Cerebri)
03/2023 - 01/2016
3Chromothripsis
12/2021 - 08/2012
3Pinealoma (Pineoblastoma)
01/2020 - 08/2011
3Sarcoma (Soft Tissue Sarcoma)
01/2018 - 11/2014
3Chromosome Aberrations (Chromosome Abnormalities)
11/2010 - 03/2007
3Meningioma (Meningiomas)
01/2007 - 09/2002
2Genomic Instability
12/2019 - 06/2016
2Typical Teratoid Rhabdoid Tumor
01/2019 - 12/2012
2Ganglioglioma
10/2018 - 01/2017
2Intellectual Disability (Idiocy)
11/2012 - 01/2012
1Pleomorphic Adenoma
11/2021
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021
1Turcot syndrome
01/2021
1Second Primary Neoplasms (Neoplasms, Second)
01/2021

Drug/Important Bio-Agent (IBA)

26DNA (Deoxyribonucleic Acid)IBA
12/2023 - 12/2005
24Proteins (Proteins, Gene)FDA Link
12/2022 - 01/2002
19RNA (Ribonucleic Acid)IBA
12/2023 - 11/2003
19Biomarkers (Surrogate Marker)IBA
12/2022 - 07/2002
14Formaldehyde (Formol)FDA Link
12/2022 - 04/2011
14ParaffinIBA
12/2022 - 06/2011
13Messenger RNA (mRNA)IBA
01/2020 - 11/2003
10MicroRNAs (MicroRNA)IBA
01/2020 - 04/2009
9ChromatinIBA
12/2020 - 01/2012
7Histones (Histone)IBA
12/2020 - 01/2012
6Phosphotransferases (Kinase)IBA
01/2023 - 01/2015
4Transcription Factors (Transcription Factor)IBA
01/2023 - 06/2011
4ProteomeIBA
01/2022 - 10/2018
4Small Interfering RNA (siRNA)IBA
01/2018 - 05/2008
3Mitogen-Activated Protein KinasesIBA
01/2023 - 08/2013
3CateninsIBA
01/2023 - 11/2010
3NucleotidesIBA
11/2021 - 01/2016
3AntibodiesIBA
01/2019 - 01/2002
3Telomerase (Telomerase Reverse Transcriptase)IBA
09/2017 - 12/2013
3Histone Deacetylase InhibitorsIBA
12/2012 - 06/2010
3Tumor Suppressor Protein p14ARF (p14ARF)IBA
05/2003 - 01/2002
2SynaptophysinIBA
03/2023 - 01/2023
2Indicators and Reagents (Reagents)IBA
01/2021 - 11/2012
2ErbB Receptors (EGF Receptor)IBA
01/2021 - 04/2006
2RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2020 - 11/2012
2Methotrexate (Mexate)FDA LinkGeneric
01/2020 - 11/2017
22,6-dinitrotoluene (DNT)IBA
01/2018 - 01/2017
2Dactinomycin (Actinomycin)FDA LinkGeneric
11/2017 - 09/2016
2Doxorubicin (Adriamycin)FDA LinkGeneric
11/2017 - 11/2014
2TenascinIBA
01/2017 - 07/2002
2Carrier Proteins (Binding Protein)IBA
01/2017 - 10/2014
2NestinIBA
01/2016 - 11/2012
2Lysine (L-Lysine)FDA Link
11/2014 - 03/2013
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
10/2014 - 11/2011
2Sorafenib (BAY 43-9006)FDA Link
10/2014 - 08/2010
2Proto-Oncogene Proteins B-rafIBA
11/2011 - 04/2011
2Codon (Codons)IBA
01/2010 - 12/2008
2Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2010 - 12/2008
2Type II DNA Topoisomerases (Topoisomerase II)IBA
05/2003 - 09/2002
2Cyclin AIBA
09/2002 - 07/2002
2Cyclin-Dependent Kinases (cdk Proteins)IBA
07/2002 - 01/2002
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2002 - 07/2002
2AntigensIBA
07/2002 - 07/2002
1tyrosine receptor (receptor, tyrosine)IBA
01/2023
1ulixertinibIBA
01/2023
1VimentinIBA
12/2022
1Reticulin (Reticular Fiber)IBA
01/2022
1sonidegibIBA
01/2022
1IonsIBA
12/2021
1Poly(ADP-ribose) Polymerase InhibitorsIBA
12/2021
1CarbonIBA
12/2021
1Retinaldehyde (Retinal)IBA
11/2021
1Tricarboxylic AcidsIBA
10/2021
1Metformin (Glucophage)FDA LinkGeneric
10/2021
1Hypoglycemic Agents (Hypoglycemics)IBA
10/2021
1acetyl- glycyl- valyl- allo- isoleucyl- seryl- glutaminyl- isoleucyl- arginyl- prolyl- cysteinamideIBA
01/2021
1PLX5622IBA
01/2021
1PeptidomimeticsIBA
01/2021
1Thrombospondin 1IBA
01/2021
1Vardenafil Dihydrochloride (Levitra)FDA Link
01/2021
1ManganeseIBA
01/2021
1Macrophage Colony-Stimulating FactorIBA
01/2021
1Arsenic Trioxide (Trisenox)FDA Link
01/2021
1Valine (L-Valine)FDA Link
12/2020
1Arginine (L-Arginine)FDA Link
12/2020

Therapy/Procedure

52Therapeutics
01/2024 - 12/2005
13Drug Therapy (Chemotherapy)
01/2023 - 05/2004
10Radiotherapy
06/2023 - 03/2004
5Transplantation
01/2021 - 11/2011
2Aftercare (After-Treatment)
01/2021 - 01/2016
2Craniospinal Irradiation
01/2020 - 01/2016
2Chemoradiotherapy
01/2016 - 03/2009
1Heavy Ion Radiotherapy
12/2021
1Cranial Irradiation
01/2021